Comparison of Postoperative Analgesia Methods in Elective Cesarean Section Surgeries
Launched by MARMARA UNIVERSITY · May 21, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
After Cesarean sections, several factors play a role in the formation of postoperative pain, including parietal stimulation originating from the surgical incision, visceral stimulation originating from the peritoneum, and manipulation of intra-abdominal structures.
To enhance patients' rehabilitation during the postoperative period, promote lactation and infant care, and reduce hospital stays, the most appropriate postoperative analgesia method should be selected.
Since many intravenous anesthetic agents administered to the mother can cross the placental barrier and cause fetal side effec...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients over 18 years old
- • ASA II-III patients undergoing elective cesarean section
- Exclusion Criteria:
- • ASA IV patients
- • Patients with known neurologic or psychiatric disorders
- • Patients with clinically significant cardiovascular, respiratory, hepatic, renal or metabolic disease
- • Patients with alcohol or drug addiction
- • Mentally disabled patients
- • Patients with BMI\>30
- • Patients who develop massive bleeding or coagulopathy
Trial Officials
Beliz Bilgili
Principal Investigator
Marmara University
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0